期刊文献+

小四五颗粒治疗慢性肾病蛋白尿30例临床观察 被引量:3

Effect of Xiao Si Wu Granules for Chronic Renal Disease with Proteinuria:An Observation of 30 Cases
下载PDF
导出
摘要 目的:观察小四五颗粒治疗慢性肾病蛋白尿的临床疗效。方法:将60例慢性肾病蛋白尿患者随机分为治疗组、对照组各30例,2组均给予原发病基础治疗,治疗组加用小四五颗粒,对照组加用依那普利,观察2组临床疗效。结果:治疗后2组均能降低24小时尿蛋白(P<0.05),升高血浆蛋白(P<0.05);临床总有效率治疗组为93.3%,对照组为70.0%,2组比较,差异有显著性意义(P<0.05)。结论:小四五颗粒对慢性肾病蛋白尿有确切疗效,且安全性较好。 Objective:To observe the therapeutic effect of Xiao Si Wu Granules (XSWG)for the treatment of chronic renal disease with proteinuria.Methods:Sixty chronic renal disease patients with proteinuria were equally randomized into two groups:the treatment group received XSWG,and the control group received enalapril.After treatment,the therapeutic effect in the two groups was evaluated. Results:The 24-hour urinary protein volume was decreased and the plasma protein level was increased in the two groups(P<0.05).The total effective rate was 93.3% in the treatment group and 70.0% in the control group,the difference being significant(P<0.05).Conclusion:XSWG is effective and safe for the treatment of chronic renal disease with proteinuria.
出处 《新中医》 CAS 北大核心 2007年第8期33-34,共2页 New Chinese Medicine
基金 广东省自然科学基金课题(编号:013040) 广东省中医药局科研基金课题(编号:101004)
  • 相关文献

参考文献6

二级参考文献30

  • 1成玉斌,罗仁,胡志飞,欧春泉.糖尿病肾病中医辨证分型荟萃分析[J].中国中医基础医学杂志,2000,6(5):49-52. 被引量:39
  • 21,Bargman JM.Management of minimal lesion glomerulonephritis:evidence-based recommendations.Kidney Int,1999;55(suppl 70):s3
  • 32,Bugess E.Conservative treatment to slow deterioration of renal function:evidence-based recommendations.Kidney Int,1999;55(suppl 70):s17
  • 43,Burgess E.Management of focal segmental glomerulosclerosis:evidence-based recommendations.Kidney Int,1999;55(suppl 70):s26
  • 54,Jindal kk.Management of idiopathic crescentic and diffuse proliferative glomerulonephritis:evidence-based recommendations.Kidney Int,1999;55(suppl 70):s33
  • 65,Levin A.Mangement of membranoproliferative glomerulonephritis:evidence-based recommendations.Kidney Int,1999;55(suppl 70):s41
  • 76,Muirhead N.Management of idiopathic membranous nephropathy:evidence-based recommendations.Kidney Int,1999;55(suppl 70):s47
  • 87,Nolin L,Courteau M.Management of IgA nephropathy:evidence-based recommendations.Kidney Int,1999;55(suppl 70):s56
  • 98,Maschio and Marcntoni.Angiotensin convertine enzyme inhibitors in nondiabetic renal disease.Curr Opin in Nephrol and Hyperten,1998;7:253
  • 109,Manttari M,Tiula E,AlikoskiT,et al.Effects of hypertension and dyslipdemia on the decline in renal function.Hypertension,1995;26:670

共引文献98

同被引文献43

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部